We were unable to model S20 into the H3 structure; however, HA fusion inhibitors that are specific for group 2 HAs have been reported and are predicted to bind to a pocket near the same loop region in the group 2 HA structure.
To date, over 600 human miRNAs have been reported, and more than 1000 predicted miRNA genes remain to be experimentally confirmed (12, 13).
Interestingly, several-thousand-fold enhancement of the optical sensitivity of silver fractal-like surfaces has been reported, and recently, this was also predicted theoretically [14 16].
Saturation profiles in the absorption column are reported, and it is shown that the predicted saturation is in the range which is relevant for heterogeneous nucleation.
Although m.5541C > T was previously reported and predicted as "definitely pathogenic" [ 26], and our patient was the second case to show this mutation, the detailed molecular pathomechanisms of m.5541C > T —how this mutation influences mitochondrial pathophysiology, which is closely related to the variation and the severity of clinical symptoms in affected individuals— remain unclear.
On the contrary, Mloc_56463 is a putative methyltransferase and has not been reported or predicted as a GA-related gene.
Currently, ˜ 31 C2H2 zinc finger proteins have been reported and/or predicted to be transcriptional factors in yeast [ 9, 10].
Previously, in large cohort studies, a number of biochemical parameters (other than C-reactive protein and albumin that compose the mGPS) including bilirubin (Temme et al, 2001), Alk phos (Tonelli et al, 2009), GGT (Kazemi-Shirazi et al, 2007) and calcium (Leifsson and Ahren, 1996), have been reported to predict overall and cancer-specific survival.
It is also of interest that liver function tests, such as bilirubin (Temme et al, 2001), alkaline phosphatase (Alk phos) (Tonelli et al, 2009) and γ-glutamyl transferase (GGT) (Kazemi-Shirazi et al, 2007), as well as serum calcium (Leifsson and Ahren, 1996), have also been reported to predict cancer and non-cancer outcomes.
It is also of interest that liver function tests such as bilirubin (Temme et al, 2001), alkaline phosphatase (Tonelli et al, 2009) and γ-glutamyl transferase (Kazemi-Shirazi et al, 2007) as well as serum calcium (Leifsson and Ahren, 1996), have also been reported to predict cancer and non-cancer mortality in large cohort studies.
